Watson Health Core

IBM Watson Health aims to transform the drug development process for life sciences – from research to commercialization. IBM Watson for Drug Discovery helps accelerate breakthroughs by enabling researchers to quickly analyze, identify, and prioritize new therapeutic targets and drug combinations for future study. 


Imagine if you could: 

  • Access structured and unstructured data from disparate sources in seconds
  • Quickly uncover novel patterns and connections across domains and therapeutic areas
  • Look beyond the known candidates to predict and generate new hypotheses
  • Focus your time and resources investigating selected targets supported by evidence

Sign up to watch the replay of our webinar, “Using Watson to Accelerate Drug Discovery,” to see how Watson can help empower you to make more informed pipeline decisions so that you can accelerate how quickly drugs can reach patients.

Speakers:

Van Willis
IBM Watson Health, Senior Consultant

University of Colorado Denver School of Medicine
PhD, Molecular Biology
 
Brigham Young University
Microbiology


Alix Lacoste
Data Scientist & Subject Matter Expert, IBM Watson for Drug Discovery

Harvard University
PhD,. Molecular and Cell Biology
 
University of California, Berkeley
B.A, Molecular and Cell Biology


Henry Chen
Product Manager, IBM Watson for Drug Discovery

UT Austin - McCombs School of Business
MBA

University of California, Berkeley
B.S., Electrical Engineering and Computer Science



Sign up to watch the replay